Macroeconomic & Geopolitical

Is the Tunnel Getting Longer?

February 2021 – 3 min read
In a race between vaccine research and virus mutations, logistical challenges are setting up hurdles that are lengthening the distance to the end of the tunnel. Markets have priced in a strong recovery though there are near-term concerns in the real economy.

In a race between vaccine research and virus mutations, logistical challenges are setting up hurdles that are lengthening the distance to the end of the tunnel. Governments are distributing vaccines at varying speeds and levels of efficiency. Also, each new virus strain risks putting into question the efficacy of existing vaccines. Emerging data suggest the vaccines will continue to be protective, though they may need retooling. The challenges remain daunting, and the role of fiscal and monetary policymakers providing support along the way will be key. There is still light at the end of the tunnel, it’s just that different countries may reach it at different times.

Markets have priced in a strong recovery amid hopes of a fast and smooth end to the pandemic. Credit spreads even in COVID-sensitive sectors are near pre-crisis levels. However, there are near-term concerns in the real economy, in particular as labor markets remain damaged. The tough winter months that brought high case counts and restrictions spared no region, and firms have been reluctant, or unable, to call everybody back. There are also signs that we will see different recoveries at different speeds. In Asia, where global trade has been crucial, China remains the leader; in the U.S., the pandemic has been worse, but additional fiscal stimulus has kept consumers spending; and Europe is falling slightly behind, hindered by fast virus spread, renewed restrictions, and lower income replacement than in the U.S. While the deployment of vaccines will likely support the global recovery this year, many sectors are still reeling and many challenges have yet to be overcome; this is why we stay with our central scenario of the “Not Quite Recovery."

Our baseline outlook is moderately supportive of risk assets—equities, credit and emerging markets in the medium term. After retracing much of the recent rise, U.S. Treasuries may drift slightly higher as better data arrives, but output gaps and monetary policy will keep rates near the current range. Meanwhile, sufficient accommodative policies by the European Central Bank should keep European government bonds strongly supported. In the near- term, valuations continue to look stretched and volatility is likely to persist, especially on uneven vaccine distribution and cheap liquidity in the system that is fueling speculative bets on asset prices.

While a tough winter weighs on U.S. employment, confidence, and spending, fiscal support to consumers will aid Q1 growth. With Democrats now seemingly in control, brighter prospects for further fiscal stimulus have boosted the medium-term outlook. However, spending bills, including an initial stimulus proposal and a broader set of priorities later this year, will likely face tough negotiations by a deeply divided Congress. The Federal Reserve continues to signal its commitment to accommodative monetary policy and won’t likely begin tapering asset purchases until at least 2022.

In Europe, the winter months proved damaging as partial lockdowns returned. A double-dip recession is likely leading the European recovery to lag the U.S. However, investment is set to drive improvement later this year, funded by governments and EU institutions, which both have finally learned the joys of a spending spree. Tellingly, an Italian political crisis has been triggered over how to spend government money, rather than whether to spend it.

In Asia, even China proved it is not immune to a second wave, while Japan remains stuck in the mud with high case counts, slow vaccine deployment, and weak consumers. In lieu of a widely distributed vaccine, exports are the source of strength on the path to recovery, aided by strong U.S. and recovering Chinese demand. In China, the supply-side recovery continues unabated, while demand should become a bigger source of strength this year. In Japan, despite a gloomy outlook, continued government support should limit downside risks.

Want to read the full article?

View PDF

Matteo Cominetta

Director, Economist

Agnès Belaisch

Managing Director, Chief European Strategist

Max Bennett

Analyst

Christian Floro

Associate Director

Kathryn Asher

Associate Director, Economist

Christopher Smart, PhD, CFA

Chief Global Strategist & Head of the Barings Investment Institute

Any forecasts in this material are based upon Barings opinion of the market at the date of preparation and are subject to change without notice, dependent upon many factors. Any prediction, projection or forecast is not necessarily indicative of the future or likely performance. Investment involves risk. The value of any investments and any income generated may go down as well as up and is not guaranteed by Barings or any other person. PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS.

Any investment results, portfolio compositions and or examples set forth in this material are provided for illustrative purposes only and are not indicative of any future investment results, future portfolio composition or investments. The composition, size of, and risks associated with an investment may differ substantially from any examples set forth in this material No representation is made that an investment will be profitable or will not incur losses. Where appropriate, changes in the currency exchange rates may affect the value of investments. Prospective investors should read the offering documents, if applicable, for the details and specific risk factors of any Fund/Strategy discussed in this material.

Barings is the brand name for the worldwide asset management and associated businesses of Barings LLC and its global affiliates. Barings Securities LLC, Barings (U.K.) Limited, Barings Global Advisers Limited, Barings Australia Pty Ltd, Barings Japan Limited, Baring Asset Management Limited, Baring International Investment Limited, Baring Fund Managers Limited, Baring International Fund Managers (Ireland) Limited, Baring Asset Management (Asia) Limited, Baring SICE (Taiwan) Limited, Baring Asset Management Switzerland Sarl, and Baring Asset Management Korea Limited each are affiliated financial service companies owned by Barings LLC (each, individually, an “Affiliate”).

NO OFFER: The material is for informational purposes only and is not an offer or solicitation for the purchase or sale of any financial instrument or service in any jurisdiction. The material herein was prepared without any consideration of the investment objectives, financial situation or particular needs of anyone who may receive it. This material is not, and must not be treated as, investment advice, an investment recommendation, investment research, or a recommendation about the suitability or appropriateness of any security, commodity, investment, or particular investment strategy, and must not be construed as a projection or prediction.

Unless otherwise mentioned, the views contained in this material are those of Barings. These views are made in good faith in relation to the facts known at the time of preparation and are subject to change without notice. Individual portfolio management teams may hold different views than the views expressed herein and may make different investment decisions for different clients. Parts of this material may be based on information received from sources we believe to be reliable. Although every effort is taken to ensure that the information contained in this material is accurate, Barings makes no representation or warranty, express or implied, regarding the accuracy, completeness or adequacy of the information.

Any service, security, investment or product outlined in this material may not be suitable for a prospective investor or available in their jurisdiction. Copyright in this material is owned by Barings. Information in this material may be used for your own personal use, but may not be altered, reproduced or distributed without Barings’ consent.